Sochho, STL ne US mein ekdum se entry maari hai apne naye 'Neuralis' data center connectivity portfolio ke saath. Ye launch April 20, 2026 ko Data Center World mein hua tha, aur iska goal hai AI, hyperscale computing aur edge workloads ko support karna. Company bol rahi hai ki ye modern data centers ka 'central nervous system' banega, jo super-fast processing aur complex AI systems ke liye network management dega.
Is announcement ke baad, STL ke shares ne BSE par 3.54% ki tezi dikhai, closing ₹271.75 par hui. Stock ₹262-₹267 ke beech trade ho raha tha.
Ab ye 'Neuralis' hai kya cheez? Isme ultra-high-density MMC aur MPO cabling hai 'AI whitespace' ke liye, jo GPUs ke bade clusters ko handle kar sake. Dusri taraf, ye high-speed Data Center Interconnect (DCI) needs ko bhi pura karega, jisme Celesta IBR series bhi hai, jo 6,912 rollable ribbon fibers tak carry kar sakti hai. Ye cables bend-insensitive fiber technology use karti hain aur compact designs mein high fiber density deti hain, jaise ki 864-fiber, 11.70 mm diameter wala Celesta IBR cable. Isse US hyperscale environments mein installation aasan ho jayega. Poora system STL ke vertically integrated model ko dikhata hai, fibre preform banane se lekar advanced cabling tak.
US mein AI infrastructure mein ekdum zabardast paisa lag raha hai, poori duniya mein ye market $2.5 trillion se bhi zyada hone wali hai 2026 tak. Microsoft aur Meta jaise players AI data centers mein billion dollars laga rahe hain. AWS, Azure, Google Cloud jaise cloud giants already yahan dominate kar rahe hain. Toh STL ka 'Neuralis' ke saath entry karna matlab seedha direct competition mein utarna hai.
Par bhai, sirf entry kar lena kaafi nahi hai. Sterlite Technologies ko kuch bade financial challenges face karne pad rahe hain. Company ka P/E ratio negative dikha raha hai, jo bade loss ka ishara hai. Sales growth pichle 5 saal se kam ho rahi hai (-4.96%), aur Return on Equity bhi negative hai (-0.89% pichle 3 saal mein). Earnings toh 49.6% saalana ki raftaar se gir rahi hain. Interest coverage ratio bhi low hai, aur promoter holding kam hui hai. Analyst ratings bhi mixed hain, kuch 'Buy' bol rahe hain targets ₹230-₹285 ke aas-paas, toh kuch 'Sell' ratings de rahe hain. Company ko sabit karna hoga ki woh sustainable profits bana sakti hai aur US ke established players se compete kar sakti hai, jo ki current financial halaat mein ek bada challenge hai.
Future ki baat karein toh, analysts ka average price target ₹234.6 INR ke aas-paas hai ek saal ke liye. Lekin ye numbers company ke recent financial performance se thode alag lagte hain, jahan revenues kam ho rahe hain aur P/E ratio loss dikha raha hai. 'Neuralis' portfolio US mein kitna successful hota hai aur company kitna market share capture kar paati hai, yehi iski long-term success decide karega.
